A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants with Type 2 Diabetes Mellitus

Trial Identifier:	D5670C00030
Sponsor:	MedImmune, LLC
NCTID::	NCT03745937
Start Date:	January 2019
Primary Completion Date:	May 2019
Study Completion Date:	May 2019
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	German Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Neuss, Germany, 41460

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.